Isoprostanes and phytoprostanes: Bioactive lipids

Biochimie

Volumn 93, Issue 1, 2011, Pages 52-60

  Durand, T ^a   Bultel Ponce V ^a   Guy, A ^a   El Fangour, S ^a   Rossi, J C ^a   Galano, J M ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

Biological activity; Isoprostanes; Phytoprostanes; Polyunsaturated fatty acid; Total synthesis

Indexed keywords

ISOPROSTANE; ISOPROSTANE DERIVATIVE; NEUROPROSTANE DERIVATIVE; PHYTOPROSTANE DERIVATIVE; POLYUNSATURATED FATTY ACID; PROSTANOID; UNCLASSIFIED DRUG;

CATALYSIS; CYCLIZATION; HUMAN; IN VIVO STUDY; LIPID ANALYSIS; LIPID PEROXIDATION; NONHUMAN; PEROXIDATION; REVIEW; SYNTHESIS;

EUKARYOTA;

EID: 78650512313     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.05.014     Document Type: Short Survey

References (38)

1. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism Proc. Natl. Acad. Sci. USA 87 1990 9383 9387
2. L.J. Roberts II, T.J. Montine, W.R. Markesbery, A.R. Tapper, P. Hardy, S. Chemtob, W.D. Dettbarn, and J.D. Morrow Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid J. Biol. Chem. 273 1998 13605 13612
3. A. Conconi, M. Miquel, J.A. Browse, and C.A. Ryan Intracellular levels of free linolenic and linoleic acid increase in tomato leaves in response to wounding Plant Physiol. 111 1996 797 803
4. R. Imbusch, and M.J. Mueller Formation of isoprostane F(2)-like compounds (phytoprostanes F(1)) from alpha-linolenic acid in plants Free Radic. Biol. Med. 28 2000 720 726
5. R. Colavitti, and T. Finkel Reactive oxygen species as mediators of cellular senescence IUBMB Life 57 2005 277 281
6. D. Il'yasova, A. Ivanova, J.D. Morrow, M. Cesari, and M. Pahor Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease Biomarkers 13 2008 41 51
7. L.J. Janssen Isoprostanes and lung vascular pathology Am. J. Respir. Cell Mol. Biol. 39 2008 383 389
8. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Wilztum Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenecity N. Engl. J. Med. 320 1989 915 924
9. S. Magder Reactive oxygen species: toxic molecules or spark of life? Crit. Care 10 2006 208 215
10. G.L. Milne, H. Yin, and J.D. Morrow Human biochemistry of the isoprostane pathway J. Biol. Chem. 283 2008 15533 15537
11. M.B. Kadiiska, B.C. Gladen, D.D. Baird, D. Germolec, L.B. Graham, C.E. Parker, A. Nyska, J.T. Wachsman, B.N. Ames, S. Basu, N. Brot, G.A. FitzGerald, R.A. Floyd, M. George, J.W. Heinecke, G.E. Hatch, K. Hensley, J.A. Lawson, L.J. Marnett, J.D. Morrow, D.M. Murray, J. Plastaras, L.J. Roberts II, J. Rokach, M.K. Shigenaga, R.S. Sohal, J. Sun, R.R. Tice, D.H. Van Thiel, D. Wellner, P.B. Walter, K.B. Tomer, R.P. Mason, and J.C. Barrett Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic. Biol. Med. 38 2005 698 710
12. O. Berdeaux, O. Scruel, J.L. Cracowski, and T. Durand F2-Isoprostanes: review of analytical methods Curr. Pharm. Anal. 2 2006 69 78
13. G.L. Milne, H. Yin, J.D. Brooks, S. Sanchez, L.J. Roberts II, and J.D. Morrow Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress Meth. Enzymol. 433 2007 113 126
14. A.W. Taylor, R.S. Bruno, B. Frei, and M.G. Traber Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F2-isoprostanes Anal. Biochem. 350 2006 41 51
15. S. Basu Radioimmunoassay of 8-Iso-prostaglandin F2?: an index for oxidative injury via free radical catalyzed lipid peroxidation Prostaglandins Leukot. Essent. Fatty Acids 58 1998 319 325
16. E. Mas, F. Michel, A. Guy, V. Bultel, Y. Falquet, P. Chardon, J.C. Rossi, J.P. Cristol, and T. Durand Quantification of urinary F2-Isoprostane with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry J. Chromatogr. B 10 2008 5087 5090
17. T. Durand, A. Guy, J.-P. Vidal, J. Viala, and J.-C. Rossi Total synthesis of 4(RS)-F4t-isoprostane methyl ester Tetrahedron Lett. 41 2000 3859 3862
18. M.F. Walter, J.B. Blumberg, G.G. Dolnikowski, and G.J. Handelman Streamlined F2-isoprostane analysis in plasma and urine with high- performance liquid chromatography and gas chromatography/mass spectroscopy Anal. Biochem. 280 2000 73 79
19. T.A. Mori, K.D. Croft, I.B. Puddey, and L.J. Beilin An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry Anal. Biochem. 268 1999 117 125
20. J.D. Morrow, and L.J. Roberts II Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism Methods Enzymol. 233 1994 163 174
21. A.J.J. Beckwith, and C.H. Schiesser Regio- and stereoselectivity of alkenyl radical ring closure: a theoretical study Tetrahedron 41 1985 3925 3941
22. B. Rondot, T. Durand, J.P. Girard, J.C. Rossi, L. Schio, S.P. Khanapure, and J. Rokach A free radical route to syn lactones and other prostanoid intermediates in isoprostaglandin synthesis Tetrahedron Lett. 34 1993 8245 8248
23. B. Rondot, T. Durand, J.-C. Rossi, and P. Rollin Synthesis of 3,5-dideoxy-5-iodo-1,2-O-isopropylidene-beta-l-lyxo-hexofuranose derivatives Carbohydr. Res. 261 1994 149 156
24. A. Roland, T. Durand, B. Rondot, J.-P. Vidal, and J.-C. Rossi A practical asymmetric synthesis of ent-12-epi-PGF-2 alpha methyl ester Bull. Soc. Chim. Fr. 133 1996 1149 1154
25. S. El Fangour, A. Guy, V. Despres, J.-P. Vidal, J.-C. Rossi, and T. Durand Total synthesis of the eight diastereomers of the syn-anti-syn phytoprostanes F1 types I and II J. Org. Chem. 69 2004 2498 2503
26. E. Loza, D. Lola, J. Freimanis, I. Turovskii, M. Gavars, and A. Liepina 2,5-Disubstituted furans in the synthesis of 2-cyclopentenone derivatives Latvijas PSR Zinatnu Akademijas Vestis, Kimijas Serija 4 1985 465 472
27. S. El Fangour, A. Guy, J.-P. Vidal, J.-C. Rossi, and T. Durand A flexible synthesis of the phytoprostanes B1 type I and II J. Org. Chem. 70 2005 989 997
28. E. Pinot, A. Guy, A.-L. Guyon, J.-C. Rossi, and T. Durand Enzymatic kinetic resolution of a functionalized 4-hydroxy-cyclopentenone: synthesis of the key intermediates in the total synthesis of isoprostanes Tetrahedron: Asymmetry 16 2005 1893 1895
29. E. Pinot, A. Guy, A. Fournial, L. Balas, J.-C. Rossi, and T. Durand Total synthesis of the four enantiomerically pure diasteroisomers of the phytoprostanes E1Type II and of the 15-E2t-isoprostanes J. Org. Chem. 73 2008 3063 3069
30. C. Oger, Y. Brinkmann, S. Bouazzaoui, T. Durand, and J.-M. Galano Stereocontrolled access to isoprostanes via a bicyclo[3.3.0]octene framework Org. Lett. 10 2008 5087 5090
31. I. Thoma, C. Loeffler, A.K. Sinha, M. Gupta, M. Krischke, B. Steffan, T. Roitsch, and M.J. Mueller Cyclopentenone isoprostanes induced by reactive oxygen species trigger defense gene activation and phytoalexin accumulation in plants Plant J. 34 2003 363 375
32. C. Loeffler, S. Berger, A. Guy, T. Durand, G. Bringmann, M. Dreyer, U. von Rad, J. Durner, and M.J. Mueller B1-phytoprostanes trigger plant defense and detoxification responses Plant Physiol. 137 2005 328 340
33. S. Mueller, B. Hilbert, K. Dueckershoff, T. Roitsch, M. Krischke, M.J. Mueller, and S. Berger General detoxification and stress responses are mediated by oxidized lipids through TGA transcription factors in Arabidopsis Plant Cell 20 2008 768 785
34. C. Traidl-Hoffmann, V. Mariani, H. Hochrein, K. Karg, H. Wagner, J. Ring, M.J. Mueller, T. Jakob, and H. Behrendt Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization J. Exp. Med. 201 2005 627 636
35. S. Gilles, V. Mariani, M. Bryce, M.J. Mueller, J. Ring, T. Jakob, S. Pastore, H. Behrendt, and C. Traidl-Hoffmann Pollen-derived E1-phytoprostanes signal via PPAR-{gamma} and NF-{kappa}B-dependent mechanisms J. Immunol. 182 2009 6653 6658
36. R.A. Benndorf, E. Schwedhelm, A. Gnann, R. Taheri, G. Kom, M. Didie, A. Steenpass, S. Ergun, and R.H. Boger Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A2 receptor: a potential link between oxidative stress and impaired angiogenesis Circ. Res. 103 2008 1037 1046
37. K. Karg, V.M. Dirsch, A.M. Vollmar, J.L. Cracowski, F. Laporte, and M.J. Mueller Biologically active oxidized lipids (phytoprostanes) in the plant diet and parenteral lipid nutrition Free Radic. Res. 41 2007 25 37
38. A. Barden, K. Croft, T. Durand, A. Guy, M.-J. Mueller, and T.J. Mori F1-phytoprostanes following ALA supplementation in men: a randomised controlled trial Nutrition 10 2009 1890 1895